BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25066866)

  • 1. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
    Roberts CA; Wetherell MA; Fisk JE; Montgomery C
    Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical oxygenation suggests increased effort during cognitive inhibition in ecstasy polydrug users.
    Roberts CA; Montgomery C
    J Psychopharmacol; 2015 Nov; 29(11):1170-81. PubMed ID: 26333432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updating of working memory in ecstasy polydrug users: Findings from fNIRS.
    Montgomery C; Fisk JE; Roberts CA
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. fNIRS suggests increased effort during executive access in ecstasy polydrug users.
    Roberts CA; Montgomery C
    Psychopharmacology (Berl); 2015 May; 232(9):1571-82. PubMed ID: 25391436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ; McFie L; Fleetwood H; Robinson JA
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory deficits associated with recreational use of "ecstasy" (MDMA).
    Morgan MJ
    Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Roiser JP; Rogers RD; Sahakian BJ
    Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reports of executive dysfunction in current ecstasy/polydrug Users.
    Hadjiefthyvoulou F; Fisk JE; Montgomery C; Bridges N
    Cogn Behav Neurol; 2012 Sep; 25(3):128-38. PubMed ID: 22960437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological indices of response inhibition in human polydrug users.
    Roberts CA; Fairclough S; Fisk JE; Tames FT; Montgomery C
    J Psychopharmacol; 2013 Sep; 27(9):779-89. PubMed ID: 23803689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
    Wetherell MA; Montgomery C
    Psychopharmacology (Berl); 2014 Apr; 231(7):1365-75. PubMed ID: 24190587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological evidence of atypical processing underlying mental set shifting in ecstasy polydrug and polydrug users.
    Roberts CA; Fairclough SH; McGlone FP; Fisk JE; Montgomery C
    Exp Clin Psychopharmacol; 2013 Dec; 21(6):507-15. PubMed ID: 24080019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA.
    Wetherell MA; Atherton K; Grainger J; Brosnan R; Scholey AB
    Hum Psychopharmacol; 2012 Mar; 27(2):167-76. PubMed ID: 22389081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC; Parrott AC; Turner JJ
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.